Drug intelligence / Profile preview

dexamethasone + tylosin

Development stage
Unknown
Lead developer
Wayzon Pharma
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Delta-Tylo-Wayzon Pharma is a veterinary combination product developed by Wayzon Pharma. It contains tylosin, a macrolide antibiotic, and dexamethasone, a potent synthetic glucocorticoid. Tylosin exerts its antibacterial effect by binding to the 50S ribosomal subunit of susceptible bacteria, thereby inhibiting protein synthesis. It is particularly effective against Gram-positive bacteria and Mycoplasma species. Dexamethasone provides anti-inflammatory and immunosuppressive effects by activating glucocorticoid receptors, which modulates gene expression to reduce the production of inflammatory mediators. This combination is typically used to treat respiratory and systemic infections in livestock where both antibacterial action and the reduction of associated inflammation are required.

Brand names
Delta-Tylo-Wayzon PharmaDelta-Tylo
Other names
Tylosin and Dexamethasone
02

Targets

GR (Glucocorticoid receptor)Bacterial 50S ribosomal subunit

Beyond the preview

Go deeper on dexamethasone + tylosin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + tylosin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call